DxLab Inc.
PrivateLast Round
Accelerator
Sep 23, 2024
Total Funding Raised
$5.25M
Company Overview
DxLab Inc. is a biotechnology company that develops and commercializes point-of-care diagnostic solutions for rapid, on-site detection of dangerous pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DxLab Inc. Comparables
Compare DxLab Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProtonDx | 83% | |
| Anavasi Diagnostics | 83% | |
| Biomeme | 80% |
DxLab Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 23, 2024 | ||||
| Grant | Jun 7, 2024 | ||||
| Seed | Dec 23, 2020 |
DxLab Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neoteny | Seed |
| Greentown Labs | Seed |
| Ambrosia Investments | Seed |
| Unlock Capital | Accelerator |
| The E14 Fund | Seed |
| AFVentures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2026
Monthly visitors grew 91% MoM, reaching 2K.
- Nov 7, 2025
Monthly visitors increased 246% MoM, from 306 to 1.1K.
DxLab Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access